Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 4, 2007, Pages 1559-1562

  Baltch, Aldona L ^a,b   Ritz, William J ^a,b   Bopp, Lawrence H ^a   Michelsen, Phyllis B ^a,b   Smith, Raymond P ^a,b  

^a STRATTON VA MEDICAL CENTER   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; GENTAMICIN; OXACILLIN; RIFAMPICIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BROTH MEDIUM; CELL ISOLATION; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFICACY; EVALUATION; HUMAN; HUMAN CELL; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MONOCYTE; MONOCYTE DERIVED MACROPHAGE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DRUG COMBINATIONS; GENTAMICINS; HUMANS; MICROBIAL SENSITIVITY TESTS; MONOCYTES; OXACILLIN; RIFAMPIN; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 34247102790     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00973-06     Document Type: Article

References (17)

1. Barcia-Macay, M., C. Seral, M.-P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke. 2006. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrob. Agents Chemother. 50:841-851.
2. Brouillette, E., G. Grondin, L. Shkreta, P. Lacasse, and B. G. Talbot. 2003. In vivo and in vitro demonstration that Staphylococcus aureus is an intracellular pathogen in the presence or absence of fibronectin-binding proteins. Microb. Pathog. 35:159-168.
3. Carlyn, C. J., A. L. Baltch, W. J. Ritz, and R. P. Smith. 2006. Daptomycin in the treatment of persistent bacteremia with invasive complications caused by a small colony variant of methicillin-resistant Staphylococcus aureus in an orthopedic patient. Infect. Dis. Clin. Pract. 14:394-398.
4. Carryn, S., H. Chanteux, C. Seral, M.-P. Mingeot-Leclercq, F. Van Bambeke, and P. M. Tulkens. 2003. Intracellular pharmacodynamics of antibiotics. Infect. Dis. Clin. N. Am. 17:615-634.
5. Cilli, F., S. Aydemir, and A. Tunger. 2006. In vitro activity of daptomycin alone and in combination with various antimicrobials against Gram-positive cocci. J. Chemother. 18:27-32.
6. Kapral, F. A., and M. G. Shayegani. 1959. Intracellular survival of staphylococci. J. Exp. Med. 110:123-128.
7. Leuthner, K. D., C. H. Cheung, and M. J. Ryback. 2006. Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 58:338-343.
8. Liu, P., and H. Derendorf. 2003. Antimicrobial tissue concentrations. Infect. Dis. Clin. N. Am. 17:599-613.
9. Mandell, G. L., and T. K. Vest. 1972. Killing of intraleukocytic Staphylococcus aureus by rifampin in vitro and in vivo studies. J. Infect. Dis. 125:486-490.
10. Micklefield, J. 2004. Daptomycin structure and mechanism of action revealed. Chem. Biol. 11:887-888.
11. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard. NCCLS publication no. M7-A6. National Committee for Clinical Laboratory Standards, Wayne, PA.
12. Pascual, A. 1995. Uptake and intracellular activity of antimicrobial agents in phagocytic cells. Rev. Med. Microbiol. 6:228-235.
13. Proctor, R. A., P. van Langevelde, M. Kristjansson, J. N. Maslow, and R. D. Arbeit. 1995. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin. Infect. Dis. 20:95-102.
14. Sader, H. S., J. M. Streit, T. R. Fritsche, and R. N. Jones. 2004. Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide. Diagn. Microbiol. Infect. Dis. 50:201-204.
15. Steenbergen, J. N., J. Alder, G. M. Thorne, and F. P. Tally. 2005. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J. Antimicrob. Chemother. 55:283-288.
16. Van der Auwera, P., T. Matsumoto, and M. Husson. 1988. Intraphagocytic penetration of antibiotics. J. Antimicrob. Chemother. 22:185-192.
17. Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.